Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 12, 2011, Pages 8835-8848

  Laspas, Panagiotis ^a   Gramlich, Oliver W ^a   Müller, Harald D ^a   Cuny, Clemens S ^a   Gottschling, Philip F ^a   Pfeiffer, Norbert ^a   Dick, H Burkhard ^b   Joachim, Stephanie C ^b   Grus, Franz H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; KERATIN; EPITOPE; IMMUNOGLOBULIN G; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BRAIN TISSUE; CELL COUNT; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATION; DISEASE MODEL; EYE FUNDUS; GLAUCOMA; HISTOPATHOLOGY; IMMUNIZATION; INTRAOCULAR PRESSURE; MALE; MICROGLIA; NONHUMAN; OPHTHALMOSCOPY; OPTIC NERVE; PRIORITY JOURNAL; RAT; RETINA; RETINA DEGENERATION; RETINA GANGLION CELL; ANIMAL; BRAIN; DEMYELINATING DISEASE; IMMUNOLOGY; LEWIS RAT; NERVE DEGENERATION; PATHOLOGY;

ANIMALS; AUTOANTIBODIES; BRAIN; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; EPITOPES; GLAUCOMA; IMMUNIZATION; IMMUNOGLOBULIN G; INTRAOCULAR PRESSURE; KERATINS; MALE; MICROGLIA; NERVE DEGENERATION; NERVE TISSUE PROTEINS; OPTIC NERVE; RATS; RATS, INBRED LEW; RETINAL GANGLION CELLS;

EID: 84855374090     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6889     Document Type: Article

References (70)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008;53(suppl 1):S3-S10.
3. Tezel G, Wax MB. The immune system and glaucoma. Curr Opin Ophthalmol. 2004;15:80-84.
4. Wax MB, Tezel G. Immunoregulation of retinal ganglion cell fate in glaucoma. Exp Eye Res. 2009;88:825-830.
5. Grus FH, Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Wax MB. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci. 2006;47:968-976.
6. Tezel G, Wax MB. The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J Neurosci. 2000;20:3552-3562.
7. Chiu K, Chang R, So KF. Laser-induced chronic ocular hypertension model on SD rats. J Vis Exp. 2007;(10)549.
8. Kalamkarov GR, Tsapenko IV, Zueva MV, et al. Experimental model of acute ischemia of the retina in rats. Bull Exp Biol Med. 2008;145:688-691.
9. Ma K, Xu L, Zhang H, Zhang S, Pu M, Jonas JB. Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model. Am J Ophthalmol. 2009;147:326-331.
10. Joachim SC, Grus FH, Kraft D, et al. Complex antibody profile changes in an experimental autoimmune glaucoma animal model. Invest Ophthalmol Vis Sci. 2009;50:4734-4742.
11. Wax MB, Tezel G, Yang J, et al. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. J Neurosci. 2008; 28:12085-12096.
12. Joachim SC, Wax MB, Seidel P, Pfeiffer N, Grus FH. Enhanced characterization of serum autoantibody reactivity following HSP 60 immunization in a rat model of experimental autoimmune glaucoma. Curr Eye Res. 2010;35:900-908.
13. Joachim SC, Grus FH, Kraft D, et al. Complex antibody profile changes in an experimental autoimmune glaucoma animal model. Invest Ophthalmol Vis Sci. 2009;50:4734-4742.
14. Jang JU, Lee SH, Choi CU, Bahk SC, Chung HT, Yang YS. Effects of heme oxygenase-1 inducer and inhibitor on experimental autoimmune uveoretinitis. Korean J Ophthalmol. 2007;21:238-243.
15. Kang SY, Kang JH, Choi JC, Lee JS, Lee CS, Shin T. Expression of erythropoietin in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis. J Clin Neurol. 2009;5:39-45.
16. Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129:705-733.
17. Pitz S, Moll R. Intermediate-filament expression in ocular tissue. Prog Retin Eye Res. 2002;21:241-262.
18. Irvine AD, Corden LD, Swensson O, et al. Mutations in corneaspecific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat Genet. 1997;16:184-187.
19. Kao WW, Liu CY, Converse RL, et al. Keratin 12-deficient mice have fragile corneal epithelia. Invest Ophthalmol Vis Sci. 1996;37: 2572-2584.
20. Viac J, Reano A, Brochier J, Staquet MJ, Thivolet J. Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol. 1983;81:351-354.
21. Viac J, Staquet MJ, Thivolet J, Goujon C. Experimental production of antibodies against stratum corneum keratin polypeptides. Arch Dermatol Res. 1980;267:179-188.
22. Goldblum D, Kontiola AI, Mittag T, Chen B, Danias J. Non-invasive determination of intraocular pressure in the rat eye: comparison of an electronic tonometer (TonoPen), and a rebound (impact probe) tonometer. Graefes Arch Clin Exp Ophthalmol. 2002;240:942-946.
23. Moore CG, Milne ST, Morrison JC. Noninvasive measurement of rat intraocular pressure with the Tono-Pen. Invest Ophthalmol Vis Sci. 1993;34:363-369.
24. Wang WH, Millar JC, Pang IH, Wax MB, Clark AF. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci. 2005;46:4617-4621.
25. Guo X, Sugita S. Topography of ganglion cells in the retina of the horse. J Vet Med Sci. 2000;62:1145-1150.
26. Piri N, Kwong JM, Song M, Elashoff D, Caprioli J. Gene expression changes in the retina following optic nerve transection. Mol Vis. 2006;12:1660-1673.
27. Wang J, Ge J, Sadun AA, Lam TT. Characteristics of optic nerve damage induced by chronic intraocular hypertension in rat. Yan Ke Xue Bao. 2004;20:25-29.
28. Holcombe DJ, Lengefeld N, Gole GA, Barnett NL. Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model. Br J Ophthalmol. 2008;92:683-688.
29. Li B, Barnes GE, Holt WF. The decline of the photopic negative response (PhNR) in the rat after optic nerve transection. Doc Ophthalmol. 2005;111:23-31.
30. Gramlich OW, Joachim SC, Gottschling PF, et al. Ophthalmopathology in rats with MBP-induced experimental autoimmune encephalomyelitis. Graefes Arch Clin Exp Ophthalmol. 2011;249: 1009-1020.
31. Dolan T, Fernandez-Juricic E. Retinal ganglion cell topography of five species of ground-foraging birds. Brain Behav Evol. 2010;75: 111-121.
32. Rahman ML, Kuroda K, Aoyama M, Sugita S. Regional specialization of the ganglion cell density in the retina of the ostrich (Struthio camelus). Anim Sci J. 2010;81:108-115.
33. Shinozaki A, Hosaka Y, Imagawa T, Uehara M. Topography of ganglion cells and photoreceptors in the sheep retina. J Comp Neurol. 2010;518:2305-2315.
34. Diehl KH, Hull R, Morton D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol. 2001;21:15-23.
35. Staszyk C, Bohnet W, Gasse H, Hackbarth H. Blood vessels of the rat tail: a histological re-examination with respect to blood vessel puncture methods. Lab Anim. 2003;37:121-125.
36. Ross RJ, Zhou M, Shen D, et al. Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to agerelated macular degeneration. Exp Eye Res. 2008;86:675-683.
37. Rudehill S, Muhallab S, Wennersten A, et al. Autoreactive antibodies against neurons and basal lamina found in serum following experimental brain contusion in rats. Acta Neurochir (Wien). 2006;148:199-205; discussion 205.
38. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A. 2000;97:1184-1189.
39. Gran B, Zhang GX, Yu S, et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol. 2002;169:7104-7110.
40. Ebneter A, Casson RJ, Wood JP, Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatio-temporal characterisation and correlation with axonal injury. Invest Ophthalmol Vis Sci. 2010;51:6448-6460.
41. Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH. Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr Eye Res. 2007;32:501-509.
42. Joachim SC, Reichelt J, Berneiser S, Pfeiffer N, Grus FH. Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens. Graefes Arch Clin Exp Ophthalmol. 2008;246:573-580.
43. Joachim SC, Wuenschig D, Pfeiffer N, Grus FH. IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Mol Vis. 2007;13: 1573-1579.
44. Maruyama I, Ohguro H, Ikeda Y. Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Invest Ophthalmol Vis Sci. 2000;41:1657-1665.
45. Reichelt J, Joachim SC, Pfeiffer N, Grus FH. Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension. Curr Eye Res. 2008;33:253-261.
46. Tezel G, Edward DP, Wax MB. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol. 1999;117:917-924.
47. Yang J, Tezel G, Patil RV, Romano C, Wax MB. Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci. 2001;42:1273-1276.
48. Broekhuyse RM, Kuhlmann ED, van Vugt AH, Winkens HJ. Immunological and immunopathological aspects of opsin-induced uveoretinitis. Graefes Arch Clin Exp Ophthalmol. 1987;225:45-49.
49. Broekhuyse RM, Kuhlmann ED, Winkens HJ. Experimental autoimmune anterior uveitis (EAAU), II: dose-dependent induction and adoptive transfer using a melanin-bound antigen of the retinal pigment epithelium. Exp Eye Res. 1992;55:401-411.
50. Bartsch U, Pesheva P, Raff M, Schachner M. Expression of janusin (J1-160/180) in the retina and optic nerve of the developing and adult mouse. Glia. 1993;9:57-69.
51. Keltner JL, Thirkill CE. The 22-kDa antigen in optic nerve and retinal diseases. J Neuroophthalmology. 1999;19:71-83.
52. Nagelhus EA, Veruki ML, Torp R, et al. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Muller cells and fibrous astrocytes. J Neurosci. 1998;18:2506-2519.
53. Crimando J, Cooper K, Hoffman SA. Inhibition of sodium channel currents by antineuronal autoantibody from autoimmune mice. Ann N Y Acad Sci. 1997;823:303-307.
54. Stankova I, Prokesova L, Trojan S. Is the identification of antibodies against the nervous tissue an indicator of brain injury? Physiol Res. 1999;48:383-387.
55. Rosenmann H, Grigoriadis N, Karussis D, et al. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch Neurol. 2006;63:1459-1467.
56. Gupta N, Fong J, Ang LC, Yucel YH. Retinal tau pathology in human glaucomas. Can J Ophthalmol. 2008;43:53-60.
57. Matus S, Burgos PV, Bravo-Zehnder M, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med. 2007; 204:3221-3234.
58. Whitney KD, McNamara JO. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. J Neurosci. 2000;20:7307-7316.
59. Lu XY, Chen XX, Huang LD, Zhu CQ, Gu YY, Ye S. Anti-alphainternexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis. PLoS One. 2010;5:e11124.
60. Grieshaber MC, Flammer J. Does the blood-brain barrier play a role in Glaucoma? Surv Ophthalmol. 2007;52(suppl 2):S115-S121.
61. Yang J, Patil RV, Yu H, Gordon M, Wax MB. T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am J Ophthalmol. 2001;131:421-426.
62. Xu H, Manivannan A, Jiang HR, et al. Recruitment of IFN-gammaproducing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P/E-selectin interactions. J Immunol. 2004;172:3215-3224.
63. Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J Immunol. 1998;161:4437-4446.
64. Johnson EC, Morrison JC. Friend or foe?-resolving the impact of glial responses in glaucoma. J Glaucoma. 2009;18:341-353.
65. Hernandez MR, Miao H, Lukas T. Astrocytes in glaucomatous optic neuropathy. Prog Brain Res. 2008;173:353-373.
66. Andersen MH, Schrama D, Thor Straten P, Becker JC. Cytotoxic T cells. J Invest Dermatol. 2006;126:32-41.
67. Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, Chavez R, Lascurain R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol. 2009;6:15-25.
68. Husain D, Kim I, Gauthier D, et al. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol. 2005;123:509-516.
69. Langmann T. Microglia activation in retinal degeneration. J Leukocyte Biol. 2007;81:1345-1351.
70. Marta CB, Bansal R, Pfeiffer SE. Microglial Fc receptors mediate physiological changes resulting from antibody cross-linking of myelin oligodendrocyte glycoprotein. J Neuroimmunol. 2008;196: 35-40.